Previous Article | Next Article ![]()
Mol. Cell. Biol., Feb 1995, 742-755, Vol 15, No. 2
XQ Qin, DM Livingston, M Ewen, WR Sellers, Z Arany and WG Kaelin Jr
Reintroduction of RB into SAOS2 (RB-/-) cells causes a G1 arrest and
characteristic cellular swelling. Coexpression of the cellular
transcription factor E2F-1 could overcome these effects. The ability of
E2F-1 to bind to RB was neither necessary nor sufficient for this effect,
and S-phase entry was not accompanied by RB hyperphosphorylation under
these conditions. Furthermore, E2F-1 could overcome the actions of a
nonphosphorylatable but otherwise intact RB mutant. These data, together
with the fact that RB binds to E2F-1 in vivo, suggest that E2F-1 is a
downstream target of RB action. Mutational analysis showed that the ability
of E2F-1 to bind to DNA was necessary and sufficient to block the formation
of large cells by RB, whereas the ability to induce S-phase entry required
a functional transactivation domain as well. Thus, the induction of a G1
arrest and the formation of large cells by RB in these cells can be
genetically dissociated. Furthermore, the ability of the E2F-1 DNA-binding
domain alone to block one manifestation of RB action is consistent with the
notion that RB-E2F complexes actively repress transcription upon binding to
certain E2F-responsive promoters. In keeping with this view, we show here
that coproduction of an E2F1 mutant capable of binding to DNA, yet unable
to transactivate, is sufficient to block RB-mediated transcriptional
repression.
Copyright © 1995, American Society for Microbiology
The transcription factor E2F-1 is a downstream target of RB action
Dana Farber Cancer Institute, Boston, Massachusetts 02115.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|